Acarina Pharma Private Limited
About Acarina Pharma Private Limited
Data last updated:
Acarina Pharma Private Limited is a private limited company based in Gwalior, Madhya Pradesh, India. It operates in the household goods segment of the home appliances and consumer durables sector. It was incorporated on 23 October 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U51397MP2020PTC053422.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Shaikh Shabbirhusain and Dilshad Qureshi.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Gwalior, Madhya Pradesh.
As per the financials filed for FY 2024, the company reported a revenue of ₹34,128, a decline of 15% compared to the previous year. For the same year it recorded a net loss of ₹96,426 (net margin -282.5%) and EBITDA of -₹93,017 (EBITDA margin -272.6%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressBehind 260, Tansen Nagar, Gwalior, Madhya Pradesh, India – 474002
- IndustryHome Appliances, Household Goods, Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Acarina Pharma Private Limited
The main business activity of Acarina Pharma is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Acarina Pharma Private Limited FY 2024 filings available
Acarina Pharma Private Limited reported revenue of ₹34,128 (down 15% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Acarina Pharma Private Limited
Revenue fell 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Acarina Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | -₹93,017 | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹96,426 | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Acarina Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -272.6% | •••• | •••• | •••• |
| Net Profit Margin | -282.5% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Acarina Pharma are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Acarina Pharma Private Limited
Acarina Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Other Hospital and Medical Care Activities). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cyto-Sure Private Limited | ₹35,400 (FY 2022) | •••• | •••• | •••• | Bangalore, Karnataka, India | |
| Sahaya Holistic Integrative Hospital Private Limited | ₹35,250 (FY 2024) | •••• | •••• | •••• | Bangalore, Karnataka, India | |
| Advitaarunoday Foundation | ₹35,210 (FY 2024) | •••• | •••• | 68.0% | •••• | Yavatmal, Maharashtra, India |
| Almighty Cancer Cure Foundation | ₹34,889 (FY 2021) | •••• | •••• | •••• | Bangalore, Karnataka, India | |
| Paul Hartmann Medical Private Limited | ₹34,825 (FY 2018) | •••• | •••• | -97.0% | •••• | Coimbatore, Tamil Nadu, India |
| Acarina Pharma Private Limited this company | ₹34,128 (FY 2024) | •••• | •••• | -15.0% | •••• | Gwalior, Madhya Pradesh, India |
| Healthevate Healthcare Solutions Private Limited | ₹34,100 (FY 2024) | •••• | •••• | •••• | Keshavpuram, Delhi, India | |
| Ageingpune Healthcare Private Limited | ₹33,681 (FY 2020) | •••• | •••• | •••• | Pune, Maharashtra, India | |
| Galaxy Diagnostics Private Limited | ₹33,621 (FY 2017) | •••• | •••• | 3869.0% | •••• | Uttar Pradesh, India |
| Satik Pharmaceuticals Private Limited | ₹33,620 (FY 2022) | •••• | •••• | •••• | Noida, Uttar Pradesh, India | |
| Evewen Corporate Solutions Private Limited | ₹33,542 (FY 2024) | •••• | •••• | -94.0% | •••• | Ernakulam, Kerala, India |
Peers are the five companies nearest above and the five nearest below Acarina Pharma by revenue in the same principal business activity (Other Hospital and Medical Care Activities), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Acarina Pharma Private Limited
Acarina Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shaikh Shabbirhusain Also directs: Bhrama Projects Private Limited, Growglimp Infra Private Limited | Director | 21 Nov 2024 | 1 Years 10 Months | Current |
| Dilshad Qureshi | Director | 27 Jan 2025 | 1 Years 8 Months | Current |
Charges & Borrowings of Acarina Pharma Private Limited
Acarina Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Acarina Pharma Private Limited
Employment history and EPFO contributions of people linked to Acarina Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Acarina Pharma Private Limited
Acarina Pharma Private Limited has 4 board changes on record since 2024: 2 appointments and 2 cessations. The latest: Udita Shakya ceased to be Director on 31 Jan 2025.
Credit Ratings, Litigation & Regulatory Alerts for Acarina Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Acarina Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Acarina Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Acarina Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Acarina Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Acarina Pharma Private Limited
Acarina Pharma is an active private limited company based in Gwalior, Madhya Pradesh, India. The company works in household goods, within the home appliances industry. It was incorporated on 23 October 2020 (6+ years old) and is registered under CIN U51397MP2020PTC053422.
Acarina Pharma reported revenue of ₹34,128 for FY 2024 (down 15% YoY).
Acarina Pharma has 2 current directors:
- Shaikh Shabbirhusain - Director
- Dilshad Qureshi - Director
Acarina Pharma reported a net loss of ₹96,426 (net margin -282.5%) and EBITDA of -₹93,017 (EBITDA margin -272.6%) for FY 2024, as per its filed financial statements.
The CIN (Corporate Identification Number) of Acarina Pharma is U51397MP2020PTC053422. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Acarina Pharma was incorporated on 23 October 2020, making it 6+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Acarina Pharma by revenue are Cyto-Sure Private Limited, Sahaya Holistic Integrative Hospital Private Limited, Advitaarunoday Foundation, Almighty Cancer Cure Foundation, Paul Hartmann Medical Private Limited and 5 more, all in the same principal business activity (Other Hospital and Medical Care Activities).
Udita Shakya ceased to be Director on 31 Jan 2025. Dilshad Qureshi was appointed as Director on 27 Jan 2025. Nitin Goyal ceased to be Director on 28 Nov 2024. Acarina Pharma has 4 board changes on record in total.
The registered office of Acarina Pharma is at Behind 260, Tansen Nagar, Gwalior, Madhya Pradesh, India – 474002.
Acarina Pharma has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.
Acarina Pharma operates in the home appliances industry, in the household goods segment.